October 21, 20195 min read, 1015 words
Published: October 21, 2019 | 5 min read, 1015 words
restless. It was late fall of 2017. The year was winding down, and so was his MD/PhD program at Columbia. Trying to figure out what was next in his life, he’d taken to long walks in the leaf-strewn West Village. One night as he paced up Hudson Street, his stomach filled with La C...
CRITIC REVIEWS
Lack of Reliable Sources
October 24, 2019
This is a ridiculous, unscientific puff piece for a new biofirm. CRISPR is not going to answer all the problems of genetic-linked diseases and is actually a threat to natural selection processed as it allows corporations and governments to determine what genes are allowed to thrive, which are killed.
October 24, 2019
PUBLIC REVIEWS
Investigative
October 22, 2019
Great look at this new "prime editing" technology to shock the Crispr world. This article reads like a press release at times for inventor David Liu's new company Prime Medicine, but I'm glad to see Wired covering a story that will likely fall through the cracks at other major outlets.
October 22, 2019
Balanced
October 22, 2019
It is not an easy article to understand, but it is certainly very interesting. Even if you do not have the right knowledge in the medical or scientific field with this article you will have an overview of how Crispr technology works.
October 22, 2019
Great Context
October 22, 2019
This article actually puts this medical technology, that is otherwise very complex, into layman's terms to allow even those with scant knowledge of the science to better understand. It could have been more in depth in terms of specifics, in my opinion; however, it is detailed enough to express the gist of it.
October 22, 2019
Investigative
October 24, 2019
A good read, in plain English rather than scientific jargon, of an emerging technological improvement to the CRISPR-Cas9 gene editing technique. Well sourced and devoid of drama. The human element that is added to the story makes it more accessible.
October 24, 2019